An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe

Abstract

This is the first reported evidence that the European gonococcal population susceptibility to gentamicin is similar to that reported in other world regions. Clinical trials to evaluate the therapeutic efficacy of gentamicin may be warranted.